Endometriosis Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1858 | Report Format : | Status : Upcoming |

Abstract

Global Endometriosis Treatment Market: Overview

Endometriosis is a chronic condition that is painful, where the tissues that outline the uterus externally (found in the fallopian tubes, ovaries, and ligaments that support the uterus) ruptures and causes inflammation and internal bleeding. This can cause infertility, adhesions, pain, scar tissue formation, and bowel problems. Symptoms of the disease include painful bowel movements during periods, pain with sex, pain before and during periods, infertility, painful urination during periods, fatigue, and other gastrointestinal problems such as diarrhea, nausea, and constipation.

Global Endometriosis Treatment Market: Segmentation

The market for the endometriosis treatment is globally fragmented into its drug type, treatment type, and distribution channel. On the basis of the drug type, the global market is segregated into gonadotropins releasing hormone agonists, progestin, non-steroidal anti-inflammatory drugs, and oral contraceptive pills. Depending on the treatment type, the market is categorized into hormonal therapies and pain management. According to the distribution channel, the market is bifurcated into hospital pharmacies, drug stores, mail order pharmacies, retail pharmacies, e-commerce, and others.

Global Endometriosis Treatment Market: Growth Factors

Endometriosis can be defined as a condition which is painful and leads to infertility. Most of the women, to avoid this condition take up all the treatments that are possible which may include surgery. Patients suffering from endometriosis should take up the treatment as soon as possible as it may affect the patient’s quality of life. Thus, the factors that attribute to affect the growth of the global market positively is the increasing female population that is in the reproductive age, high awareness rate for the disease, and the availability of better medications. There are certain factors that restrain the growth of the market such as the time that is taken to diagnose the disease is high, which is estimated by the researchers as seven to nine years. Till now, there are no diagnostic tests available that are non-invasive.

Global Endometriosis Treatment Market: Regional Analysis

Region-wise, the global endometriosis treatment market is diversified into regions such as North America, Western Europe, Eastern Europe, Asia-Pacific, the Middle East and Africa, and Latin America. The market that is expected to have the highest revenue growth in the coming years in the market of endometriosis treatment is North America as compared to other regional markets. Factors that contribute to this market growth are higher treatment costs, higher disability losses, and the large number of reproductive population that are suffering from endometriosis. The factors that are slowing down the growth of the market in the regions such as Asia Pacific and the Middle East and Africa are the lack of awareness about the disease and the treatment among the physicians and reduced rate of publication of the results. The factors that will support the market growth in this region are the regimes for minimally invasive treatment and non-hormonal treatments and the increasing efforts that are made towards the development of the drugs.

Global Endometriosis Treatment Market: Competitive Players

The key market players that are involved in the endometriosis treatment market include Eli Lilly and Company, AstraZeneca Plc., Bayer AG, Astellas Pharma, Abbvie, Meditrina Pharmaceuticals, Pfizer Inc., Neurocrine Biosciences Inc., and Takeda Pharmaceutical Company.

Global Endometriosis Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Veterinary Anti-Infectives Market by Species Type (Livestock and Companion), by Drug Class (Antimicrobial, Antiviral, Antifungal and Antiparasitic Agents), by Mode of Administration (Oral, Parenteral and Topical) and End-users (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2510 | Report Format:

The report covers forecast and analysis for the veterinary anti-infectives market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the veterinary anti-infectiv...Read More

Acromegaly Treatment Market by Disease type (Ectopic Acromegaly and Pseudo Acromegaly), Diagnosis Type include Medical Imaging and Medical Laboratory Test and Treatment Type include Medication, surgery and Radiation Therapy: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2507 | Report Format:

The report covers forecast and analysis for the acromegaly treatment market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the acromegaly treatment market al...Read More

year end sale
Choose License Type:
Latest Published Reports

View All Published Reports